Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density

por Rymuza, Joanna, Popow, Michał, Żurecka, Zuzanna, Przedlacki, Jerzy, Bednarczuk, Tomasz, Miśkiewicz, Piotr
Publicado 2018

Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays

por Bluszcz, Gabriela A., Bednarczuk, Tomasz, Bartoszewicz, Zbigniew, Kondracka, Agnieszka, Walczak, Klaudia, Żurecka, Zuzanna, Demkow, Urszula, Miśkiewicz, Piotr
Publicado 2018